Safety, Tolerability and Pharmacokinetics of MCI-186 in Patients with Acute Ischemic Stroke: New Formulation and Dosing Regimen

Publisher： Karger

E-ISSN： 1421-9786|36|3|196-204

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.36, Iss.3, 2013-10, pp. : 196-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fibrinolytic Treatment of Acute Ischemic Stroke for Patients on New Oral Anticoagulant Drugs

Cerebrovascular Diseases, Vol. 32, Iss. 6, 2011-12 ,pp. : 616-619

Karger

Access to resources Recommend Favorite

Chitotriosidase in Patients with Acute Ischemic Stroke

European Neurology, Vol. 54, Iss. 3, 2005-12 ,pp. : 149-153

Karger

Access to resources Recommend Favorite

The AMPA Antagonist ZK 200775 in Patients with Acute Ischaemic Stroke: A Double-Blind, Multicentre, Placebo-Controlled Safety and Tolerability Study

Cerebrovascular Diseases, Vol. 20, Iss. 5, 2005-11 ,pp. : 304-309

Karger

Access to resources Recommend Favorite

Hydroxyethyl Starch for Hypervolemic Hemodilution in Patients with Acute Ischemic Stroke: A Randomized, Placebo-Controlled Phase II Safety Study

Cerebrovascular Diseases, Vol. 14, Iss. 1, 2002-06 ,pp. : 33-41

Karger

Access to resources Recommend Favorite

Cardiovascular Safety of Lubeluzole (Prosynap^®) in Patients with Ischemic Stroke

Cerebrovascular Diseases, Vol. 8, Iss. 5, 1998-08 ,pp. : 247-254

Karger

Access to resources Recommend Favorite